To guide future need for cheap resistance tests for use in low income settings, we assessed cost-effectiveness of drug resistance testing as part of monitoring of people on first line ART - with switching from first to second line ART being conditional on NNRTI drug resistance mutations being identified.
Phillips, A., Cambiano, V., Nakagawa, F., Magubu, T., Miners, A., Ford, D., Pillay, D., De Luca, A., Lundgren, J., Revill, P., Cost-effectiveness of HIV drug resistance testing to inform switching to second line antiretroviral therapy in low income settings, <<PLOS ONE>>, 2014; 9 (10): e109148-e109148. [doi:10.1371/journal.pone.0109148] [http://hdl.handle.net/10807/63937]
Cost-effectiveness of HIV drug resistance testing to inform switching to second line antiretroviral therapy in low income settings
De Luca, Andrea;
2014
Abstract
To guide future need for cheap resistance tests for use in low income settings, we assessed cost-effectiveness of drug resistance testing as part of monitoring of people on first line ART - with switching from first to second line ART being conditional on NNRTI drug resistance mutations being identified.
| File | Dimensione | Formato | |
|---|---|---|---|
|
unpaywall-bitstream-1530907274.pdf
accesso aperto
Tipologia file ?:
Versione Editoriale (PDF)
Licenza:
Creative commons
Dimensione
3.11 MB
Formato
Adobe PDF
|
3.11 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
